(OTC:DHNA), (OTCBB:AKMN), (OTC:NXSL), (OTCBB:PGSI).

Turning Pennies into dollars: (OTC:DHNA), (OTCBB:AKMN), (OTC:NXSL), (OTCBB:PGSI).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://dhna.realpennies.com

(OTC:DHNA) Dhanoa Minerals Ltd.

Ecuador President and Top Officials Set the Stage for 'Responsible Mining Practices'

LAST $0.10 USD

Monday April 28, 1:55 pm ET

LAS VEGAS- Incumbent President Correa repeated statements that "RESPOSIBLE MINING' will go ahead in Ecuador. He said that the purpose of the new mining mandate was to allow the government to get its house in order and new mining laws in place so that responsible mining can proceed.

The president invited all the mining companies, including Dhanoa Minerals, Ltd. , to meet with the ministry starting recently, April 28th, to help formulate the new mining laws. The government plans to have a final version of the law ready by late May, 2008, mines ministry officials stated.

Dhanoa Minerals Ltd. is a permitted and responsible junior gold producer in Ecuador. Dhanoa commenced gold production from Guanache, Mollopongo and Bonanza Mines in the spring of 2007.

About Dhanoa-www.dhanoaminerals.com

Dhanoa is a production stage company formed to acquire, explore, and develop natural resource properties. Activities include gold production and sales, further development of the Company's business plan and raising capital. The Company has recently initiated a new program to evaluate undervalued assets for potential addition to its mineral claim portfolio.

For more info: http://akmn.realpennies.com

(OTCBB:AKMN) AskMeNow, Inc.

AskMeNow and MoneyChannel Launch Mobile Finance Portal

LAST $0.09 USD

Monday April 28, 9:15 am ET

IRVINE, Calif.-AskMeNow and The Money Channel Inc. have announced the launch of ?MoneyChannel Mobile,? a financial information portal powered by AskMeNow. The fully-automated mobile solution will give The Money Channel?s vast national Radio and Television audience of financial industry investors, consumers and insiders easy access to business, stock market and economic news, stock quotes and up the minute corporate announcements. Additionally, users have the ability to build their own unique portfolio of stock quotes, which can be accessed anytime, anywhere from mobile phones.

MoneyChannel Mobile, powered by AskMeNow, will be made available through on-air and online promotion to The Money Channel?s 4.5 million daily radio show listeners and website visitors. The branded financial information solution will also be offered to AskMeNow?s existing mobile user base and through its network of carrier distribution partners across the U. S. and Canada.

?Extending the Money Channel to the mobile world is a natural fit for our Radio and TV programming on American Scene Radio and ?WallStreetCast? and for our millions of listeners and viewers, and we expect this to be widely used by our audience while on the go,? said The Money Channel?s Host and CEO Steve Crowley.

AskMeNow CEO Darryl Cohen stated, ?We are very excited to launch our first new publishing partner solution through the AskMeNow 3.0 portal. Stock quotes and financial news are a great fit with our heavy user base of smartphone prosumers who are always looking for relevant info from their phones.?

The portal is free to use and revenues will be generated through relevant targeted advertising placed on the site. The version of the solution launching recently will be based on a mobile website, with future iterations planned to include SMS queries, closing bell market messages, and customizable stock quote alerts scheduled to update users on the companies they are watching closest.

MoneyChannel Mobile can be accessed on any mobile web enabled phone by visiting http://money.askmenow.com or by texting the keyword MONEY to the US short code 27563 .

About AskMeNow:

Founded in 2004, AskMeNow Inc. is an Irvine, Ca based public corporation trading on the NASDAQ Bulletin Boards. Specializing in mobile and desktop search and content delivery, AskMeNow's solutions for publishers, advertisers and individuals provide singular, relevant answers through a highly sophisticated content delivery system. AskMeNow is also the owner and creator of askwiki.com, a natural language search engine created to provide individuals improved search of the Wikipedia.org knowledgebase. AskMeNow?s consumer mobile search solution offers easy access to news, sports, weather, finance, travel information, comparison shopping and a host of desirable content. It is available using SMS, client applications or the WAP 2.0 site m.askmenow.com.

About The Money Channel:

The Money Channel is a national producer of Radio Programming and Television Programs that are dedicated to investor and consumer education. Founded by Steve Crowley, a former CPA and Money Editor for GOOD MORNING AMERICA, the Money Channel currently produces Steve Crowley?s AMERICAN SCENE which airs on more 500 radio stations daily plus the Internet, and WallStreetCast, a weekly half-hour TV program that airs on FOX BUSINESS every Sunday morning. For more information, visit moneychannel.tv.

For more info: http://nxsl.realpennies.com

(OTC:NXSL) NexTech Solutions, Inc.

NexTechFAS Invited to Present at Display Week 2008, the Annual Society for Information Display International Symposium and Exhibition

LAST $0.69 USD

Monday April 28, 8:00 am ET

AUSTIN, TX-Apr 28, 2008 - NexTech Solutions, Inc. and FAS Holdings Group, LLC, jointly doing business as "NexTechFAS," are pleased to announce that the company has been invited to present at the SID/Cowen and Company Display Investors Conference held at the Annual Society for Information Display Investors Conference on May 20 and 21, 2008 as a part of Display Week. NexTechFAS will present on Wednesday, May 21, 2008 at 12:30 p.m. pacific daylight time.

NexTechFAS will present its latest technology and illustrate why it is instrumental in the commercialization of different products within the display industry such as LCD, OLED, touch screen, flexible displays as well as photovoltaic panels. The company's presentation will also address how NexTechFAS's technology reduces the manufacturing costs within these sectors and why the technology is vital to these emerging markets. NexTechFAS will be joining several other leading technology companies in the display supply chain presenting at this investor conference.

The SID/Cowen and Company Display Investors Conference is a part of the larger SID International Symposium, Seminar and Exhibition which has over 550 booths, 8,000 attendees and is the leading and largest showcase of emerging display technologies. Cowen and Company, LLC provides investment banking services, including underwriting and other capital raising solutions, and mergers and acquisitions advice, to emerging growth companies and has been a sponsor of the Display Investors Conference at Display Week for the past four years. For more information on the SID conference, please go to www.sid2008.org.

About NFJV, LLC

NFJV, LLC, doing business as "NexTechFAS," is the operating company of NexTech Solutions, Inc. (Stock Symbol: NXSL) and FAS Technologies, LLC, a result of a pending merger transaction between the two companies. NexTech Solutions currently owns approximately 52 percent of NexTechFAS and will own 100 percent upon completion of the final step of the merger transaction. NexTechFAS is a Delaware limited liability company with facilities in Austin and Dallas, Texas. The company is widely recognized in the industry for the development of digital fluid dispensing and a patented extrusion coating technology known as "FAS-Coat," which has become the de-facto standard in the coating processes used in the manufacture of flat panel displays . The company also delivers advanced metrology and automation solutions, and is the first to deliver a turn-key solution for manufacturing lines in the FPD, photovoltaic and semiconductor industries. NexTechFAS's stock is quoted on the Pink Sheets under the symbol NXSL. For more information, visit: http://www.nextechfas.com.

For more info: http://pgsi.realpennies.com

(OTCBB:PGSI) Pegasi Energy Resources Corp.

Pegasi Energy Resources Corporation Proved Reserves Double to 29.8 BCFE

LAST $1.96 USD

Monday April 28, 9:30 am ET

TYLER, Texas, April 28, 2008 - Pegasi Energy Resources Corp. , an East Texas based oil and gas exploration and production company, announced substantial increase in reserves based on its February updated reserve report. The increase is due to the previously reported two wells drilled. The February report reflects a reserve base 29.8 BCFE proved, 22.7 BCFE probable, and 212.0 BCFE possible. This compares to the 2007 reserve report of 15.0 BCFE proved, 21.8 BCFE probable, and 217.0 BCFE possible. All reserve numbers are calculated on the company's gross 70% working interest.

About Pegasi Energy Resources Corporation

Pegasi Energy Resources Corporation is an organic growth-oriented independent oil and gas exploration and production company, headquartered in Tyler, Texas. Pegasi is focused on a repeatable, low geological risk, high potential project in the active East Texas oil and gas region. The company's strategy is focused on establishing a portfolio of drilling opportunities to exploit undeveloped reserves to grow production, as well as undertaking exploration to grow future reserves. Additional information concerning Pegasi Energy is available at http://www.pegasienergy.com. Investor inquiries may be directed to 903-595-4139 attention David Moss.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

Sponsored by: http://www.isthemarketopen.com

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com

(OTC:TTIN), (OTCBB:CHGS), (OTCBB:USBK), (OTCBB:BKYI).

Turning Pennies into dollars: (OTC:TTIN), (OTCBB:CHGS), (OTCBB:USBK), (OTCBB:BKYI).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://ttin.realpennies.com

(OTC:TTIN) Transfer Technology International Corp.

Transfer Technology International Announces Letter of Intent to Acquire Patent Rights for Unique Wall System Fencing

LAST $0.85 USD

Monday April 28, 7:30 am ET

TAMPA, FL-Apr 28, 2008 - Transfer Technology International Corp. announced recently the signing of a Letter of Intent to acquire the intellectual property rights involving a novel methodology for wall systems and fencing. This technology, which is trademarked under the Rhino Wall Systems name, Patent # 7,146,775B2 has a history of generating revenues and has been successfully used in the Tampa Bay market for several years.

The Rhino wall system is unique due to being corrosion resistant, easily installable, and removable and can be installed for approximately half the normal cost and time of traditional concrete walls.

"We are excited about acquiring this patent and its intellectual property rights for this growing market in the wall and fencing markets," Mr. Chris Trina, Chairman and Chief Executive Officer exclaimed. "Our company will be exploring licensing partners worldwide in the construction related industries and we are very excited to add this intellectual property to our existing portfolio of patents."

Please visit us at our new website, www.ttinternationalcorp.com for more information. You will be able to find our SEC filings, press releases, our stock quote and corporate updates.

About Transfer Technology International Corp.

The company was formulated on the premise of acquiring, procuring and funding of current technologies, research and intellectual properties for the transference of these technologies for commercialization. We anticipate generating revenue from a variety of methods including transfer fees, licensing and strategic alliance fees and the sale of intellectual properties.
For more info: http://chgs.realpennies.com

(OTCBB:CHGS) China GengSheng Minerals, Inc.

China Gengsheng Minerals, Inc. Introduces New Refractory Production Line

LAST $2.85 USD

Monday April 28, 7:52 am ET

GONGYI, China, April 28 - China Gengsheng Minerals, Inc. , a leading manufacturer in China of industrial materials capable of withstanding high temperature, saving energy and boosting productivity in certain industries such as steel and oil, recently announced that it has completed the construction of an all-new production line for the pressed bricks, a type of "shaped" refractory, for steel production. The annual designed production capacity is 15,000 metric tons. The line has begun its commercial production, with sales ensuing immediately.

Prior to the new line, Gengsheng had the capacity of 100,000 tons per year for the monolithic refractory, which is an "unshaped" heat-resistant industrial material mixed, stirred and formed at the desired location. The "shaped" refractory is a standard-sized, block-shaped brick that can be mass- manufactured for different customers. Gengsheng's new line, housed in a new facility separate from the monolithic production site, is designed to make specialized pressed bricks that contain little to no carbon and are more durable than average refractory bricks, and will be used for the production of low-carbon steel. The average price for Gengsheng's specialty pressed bricks is expected to be more than twice that of the monolithcs.

"Our new pressed-brick line will add a high-value product to our refractory offerings," said Mr. Shunqing Zhang, Chairman, CEO and President of Gengsheng. "We are currently selling the product to our full-service customers as an extra value of the program. We expect the sales of the bricks to contribute about 10% of our revenues this year."

Gengsheng's full-service programs cover installation, maintenance and replacement of refractory products for customers. Such programs accounted for 37% of the Company's total sales in 2007.

About China Gengsheng Minerals, Inc.

China Gengsheng Minerals, Inc. develops, manufactures and markets a broad range of mineral-based industrial material products, including monolithic refractories, industrial ceramics and fracture proppants. A market leader offering customized solutions, Gengsheng sells its products primarily to the iron-and-steel industry as heat-resistant components for steel-making furnaces, industrial kilns and other high-temperature vessels to guarantee and improve the productivity of those expensive pieces of equipment while reducing their consumption of energy. Founded in 1986 and based in China's Henan province, Gengsheng currently has over 200 customers in the iron, steel, oil, glass, cement, aluminum and chemical businesses located in China and in 11 other countries. Gengsheng conducts business through Gengsheng International Corporation, a British Virgin Islands company, and its Chinese subsidiaries, which are Henan Gengsheng Refractories Co., Ltd., Zhengzhou Duesail Fracture Proppant Co., Ltd. and Henan Gengsheng High Temperature Materials Co., Ltd.

For more info: http://usbk.realpennies.com

(OTCBB:USBK) USA Bank

USA Bank Reports Operating Results for the Quarter Ended March 31, 2008

LAST $2.25 USD

Monday April 28, 6:00 pm ET

PORT CHESTER, NY-Apr 28, 2008 - USA Bank reported a net loss of $746 thousand ($0.13 per share) for the quarter ended March 31, 2008, which is a marked improvement compared to the net loss of $1.5 million ($0.26 per share) for the quarter ended March 31, 2007.

The Bank continues to leverage upon its capital base with quality loan growth, which is reflected in the $1.4 million increase in interest income in the first quarter of 2008 as compared to the first quarter of 2007, which has contributed to the increase in net interest income of $525 thousand for the same periods. Also benefiting the first quarter 2008 was the recognition of a gain on sale of securities of $146 thousand and a $344,000 reduction in salaries and employee benefits, primarily reflecting staff reductions since March 31, 2007. The first quarter 2008 reflects a larger provision for loan and lease loss expense of $225 thousand (as compared to $171 thousand for the quarter ended March 31, 2007), primarily caused by increased loan volume. There was also an unfavorable variance in FDIC insurance expense, which was $113 thousand for the first quarter of 2008 (as compared to $4 thousand for the quarter ended March 31, 2007), reflecting both increased deposit volume and insurance rates.

Total assets increased $26.3 million to $195.8 million at March 31, 2008 from $169.5 million at December 31, 2007, and an increase of $87.6 million, or 81%, since March 31, 2007. As of March 31, 2008, total deposits have increased to $149.5 million, an increase of $26.7 million, or 22%, since year end 2007, and an increase of $67.5 million, or 82%, since March 31, 2007. As of March 31, 2008, total gross loans have increased to $129.6 million, which represents an increase of $22.6 million, or 21%, since year end 2007, and an increase of $53.8 million, or 71%, since March 31, 2007. Capital ratios continue to be strong, with Tier One Capital to average assets of 13.21%, Tier One Capital to risk-weighted assets of 17.12%, and Total Capital to risk-weighted assets of 18.21%.

President & CEO Gentile stated that "although results are improving, we still have a long way to go. Legal and professional fees continue to be a drag on operations, with such costs aggregating $511 thousand during the recent quarter." He further noted, "I am hopeful that the Federal Reserve Board rate reductions will serve to further reduce our total cost of funds, which remains far too high at 4.64% (1st quarter 2008 average), although it is down from 4.77% and 4.83%, during the 4th quarter 2007 and 1st quarter 2007, respectively."

Mr. Gentile also indicated that asset quality remains manageable, with non-performing loans aggregating $3.7 million, which is only $100 thousand higher than at year end 2007. And, the four loans secured by real estate continue to reflect sufficient equity to protect against further losses. One of the secured loans is within about 60 days of becoming Other Real Estate Owned, as a result of a recent judgment in our favor.

Lastly, Mr. Gentile reported that he remains optimistic that net losses will be narrowing considerably over the successive quarters of 2008, due to the efforts of the Bank's Board of Directors, Senior Management and Staff.

For more info: http://bkyi.realpennies.com

(OTCBB:BKYI) BIO-key International, Inc.

BIO-key Granted Image Identification System Patent for Award Winning Biometric Technology

LAST $0.11 USD

Monday April 28, 7:00 am ET

Patented BIO-key software delivers consistent quality images, resulting in higher accuracy and better user experience

WALL, N.J., April 28 - BIO-key International, Inc. , a leader in finger-based biometric identification and wireless public safety solutions, recently announced that on April 15, 2008, the U.S. Patent and Trademark Office issued US patent No. 7,359,553 covering BIO-key's image enhancement and data extraction core algorithm components.

The first feature of the newly patented algorithm covers BIO-key's unique capability to quickly and accurately transform a fingerprint image into a computer image that can be analyzed to determine the critical data elements. Another component of the Image Identification System covered by this patent is the ability to quickly match an image among thousands or more of image models . The ability to quickly provide feedback without compromising accuracy is a key ingredient for any biometric identification solution.

"Superior image analysis and parsing is a critical element of any highly accurate fingerprint matching algorithm," stated Mira LaCous, BIO-key's Vice President of Technology and Development. "This patent is a testament to our company's strength in creating new approaches to improve the speed and accuracy of our core technology. We continue to focus our efforts towards building upon each achievement and uncovering new ways to improve the accuracy, speed, convenience and security of our biometric solutions."

"This most recent patent is another step in protecting our rich portfolio of intellectual property, which enhances the overall value of our company," added Mike DePasquale, President and CEO of BIO-key. "Combined with our superior performance as validated by the recent NIST (National Institute of Standards & Technology) test results, and our many successful deployments in both government and commercial applications, BIO-key is well positioned to capitalize on the growing need for fast, accurate and convenient identification solutions."

About BIO-key

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions and information services to law enforcement departments, public safety agencies, government and private sector customers. BIO-key's mobile wireless technology provides first responders with critical, reliable, real-time data and images from local, state and national databases. BIO-key's high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise data to improve security, convenience and privacy and to reduce identity theft. Over 750 police departments in North America use BIO-key solutions, making BIO-key the leading supplier of mobile and wireless solutions for law enforcement.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

Sponsored by: http://www.isthemarketopen.com

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com

(OTCBB:ADXS), (OTCBB:AMXG), (OTC:ALMY), (OTC:PRPM).

Turning Pennies into dollars: (OTCBB:ADXS), (OTCBB:AMXG), (OTC:ALMY), (OTC:PRPM).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://adxs.realpennies.com

(OTCBB:ADXS) Advaxis, Inc.

Crystal Research Associates, LLC Issues Executive Informational Overview ) on Advaxis, Inc.

LAST $0.11 USD

Monday April 28, 8:30 am ET

Advaxis, Inc. uses live, genetically modified Listeria monocytogenes to safely create vaccines that stimulate multiple immune responses against cancer as well as infectious and immune disorders. Through patented techniques, the Company engineers the Listeria bacteria to secrete a specific antigen. The recipients' immune system recognizes and processes that antigen in order to provoke an immune attack against the cancer. Advaxis' Listeria platform technology is licensed from the University of Pennsylvania, where it has been developed over the past 15 years by Dr. Yvonne Paterson, the scientific founder of the Company and current chair of its Scientific Advisory Board.

At present, Advaxis is engineering Listeria to fight cervical intraepithelial neoplasia and cervical, head and neck, prostate, breast, and other cancers. The cancer vaccine market is forecast to reach over $8 billion by 2012, up from $481 million in 2007. In preclinical studies, Listeria-based cancer vaccines have a 100% therapeutic response rate and consistently provoke tumor regression, completely eliminating tumors in over 50% of mice. Moreover, animals dosed with these vaccines show a long-term immunity against cancer, with new tumor cells unable to grow. This suggests that the technology can not only treat existing tumors but may also prevent cancer recurrence.

In 2007, Advaxis completed its first human clinical trial of the Listeria platform using Lovaxin C, a vaccine for human papillomavirus -derived cervical cancer. In the Phase I trial, the vaccine has been shown to be safely administered to humans and well tolerated. To Advaxis' knowledge, it is the first entity to safely administer live Listeria as an antigen carrier and immune system stimulant in humans. A Phase II clinical trial is planned for patients with CIN I/II in 2008.

About Crystal Research Associates, LLC

Crystal Research Associates, LLC is an independent research firm that provides institutional-quality, fee-based research to small and mid-cap companies. Crystal Research Associates' unique and novel product, the Executive Informational Overview® , is free of investment ratings, target prices, and forward-looking financial models. The EIO® presents a crystal clear, detailed report on a company in a manner that is easily understood by the Wall Street financial community. The EIO® details a company's product/technology/service offerings, market size, key intellectual property, leadership, growth strategy, competition, risks, audited financial statements, key events, and other such fundamental information. Crystal Research Associates has offices in New York City and Delray Beach. Crystal Research Associates has been compensated by the Company in cash of forty thousand U.S. dollars and four hundred thousand four-year Options/Warrants to purchase Advaxis' stock for its services in creating this report, for updates, and for printing costs.

For more info: http://amxg.realpennies.com

(OTCBB:AMXG) AmMex Gold Mining Corp.

AmMex 2,000 Meter Drilling Program Underway at the Concha Property in Mexico

LAST $0.11 USD

Tuesday April 29, 9:00 am ET

OTTAWA, ONTARIO-Apr 29, 2008 - AmMex Gold Mining Corp. (WKN: AOKE72) is pleased to announce that its 70% owned joint venture with EXMIN Resources has commenced a 2,000 meter first pass drilling exploration program on the 7,767 hectare Concha concession in the Melchor Ocampo district in Zacatecas, Mexico.

Layne Drilling de Mexico is contracted to conduct the 2,000 meter drill program which is planned to test a maximum hole depth of approximately 300 meters. The program is being funded by AmMex and will be managed by EXMIN Resources Inc., the project operator, in concert with AmMex Gold Mining Corp.'s technical team.

The Concha concession covers a 7 km by 2 km airborne magnetic anomaly in a valley near outcropping mineralization with several small mines and prospects that were exploited in the past. The majority of the mines in the region appear to be located in areas near similar magnetic anomalies. The geologic environment is known to be similar to that of the Melchor Ocampo and Concepcion del Oro districts, as well as the nearby Penasquito deposit, and provides an excellent and easily accessible exploration target. The region was previously explored by an international mining company, stream sediment and soil samples taken by them show anomalous precious and base metal values.

Quality Assurance

Dr. Craig Gibson, PhD., Certified Professional Geologist, and Executive Vice President of Exploration is the authorized professional geologist for EXMIN and the direct manager of operations at Concha in consultation with Bill Reed of AmMex .

About AmMex Gold

AmMex Gold Mining Corp. is a precious metals exploration company which aims to build shareholder value by acquiring precious metals assets in proven, resource-rich areas located in politically safe areas of the world with emphasis in North and South America where the Company has strong expertise.

About EXMIN

EXMIN Resources Inc. is currently focused on the exploration and development of precious metal properties of exceptional merit in the Sierra Madre gold belt of Northwestern Mexico as well as in other highly mineralized areas of Mexico.

For more info: http://almy.realpennies.com

(OTC:ALMY) Alchemy Creative, Inc.

Alchemy Creative Inc.'s Adventures of the Elements Will Be the Title Sponsor for the Livestrong across America Bicycle Tour to Raise Awareness and Funds for Cancer and the Lance Armstrong Foundation.

LAST $0.06 USD

Monday April 28, 8:00 am ET

PLANO, Texas-Alchemy Creative Inc. recently announced that its Adventures of the Elements brand will be the title sponsor for the Livestrong Across America Bicycle tour . Alchemy Creative will partner with the 501 3 nonprofit Sports Society for American Health to raise funds and awareness for the fight against cancer. The goal is to raise $100,000 for the Lance Armstrong Foundation.

On July 1, 2008 a team of bicyclists will begin a 33 day, 3300 mile trek from San Diego, CA to Washington, D.C. Adventures of the Elements tagline for the tour proclaims, ?AoE is building the next generation of cancer fighters,? by inspiring students to learn science to become future doctors, researchers, engineers, and scientists in the battle against cancer.

According to Richard James III, creator of the Adventures of the Elements and VP of Alchemy Creative, ?Approximately 1.5 million Americans will be diagnosed with cancer and another 500,000 plus patients will die from cancer this year. Cancer impacts every US citizen in some manner. I cannot think of a worthier cause for Alchemy Creative Inc. and the Adventures of the Elements to use its resources to join the Lance Armstrong Foundation in the war on cancer. I am honored to have the opportunity to cycle 3300 miles across the US with similarly minded and driven cyclists.?

Trent Di Giulio, President and founder of CAT Studios, will travel with the tour and film it in high definition. The film will be prepared for broadcast television and will cover the tour, riders, towns the tour travels through, cancer-survivor stories, the Lance Armstrong Livestrong Foundation, people met along the route, and animation.

Maximum media coverage will be secured in each town the tour traverses and citizens will be encouraged to join the cyclists as they enter the various towns and cities along the route. Each day, the cyclists will ride in honor of individuals with cancer (requires a $250 donation per individual honored).

In each city on the tour, Alchemy Creative will honor a school with Adventures of the Elements. The SiennaBlu song, ?Free,? which was composed for the Adventures of the Elements ?Water Cycle? movie soundtrack and has a theme of ?giving back,? will be the title song for the tour.

There will be more information provided in subsequent press releases. Any interested corporate sponsors must finalize their contributions by May 12, 2008 to have their corporate logos and names featured on the tour support vehicles, cycling jerseys, t-shirts, website, film, and other tour materials.

ABOUT ALCHEMY CREATIVE:

Alchemy Creative, Inc. was founded on the principle of edutainment - enabling learning with the integration of educational media into an exciting and entertaining format in which science and other curriculum learning is enhanced through actively engaging students. ALMY is producing video DVD, and developing online gaming and other media products for distribution to both the general public and school systems. Their philosophy and product offerings have rendered measurable results with children. The value of the media and products has been recognized by some of the world's most respected corporations, including several Fortune 100 companies.

ALMY creates and distributes some of America's most unique products for the edutainment sector. Currently, ALMY is using the latest, cutting-edge technology in developing future products such as DVDs, online video games, and other cutting-edge technologies to further captivate students. ALMY's goal is to revolutionize the way the children of the world progress in science learning. The company is utilizing 21st century technology and methodology in efforts to provide a more exciting environment in which children will be more apt to take interest in the traditional education requirements.

Stated simply, ALMY takes "what kids like," from card games and books to movies and video games, and makes them educational. Thus, children of all ages learn while having fun; in a sense, giving substance to "play time."

For more info: http://prpm.realpennies.com

(OTC:PRPM) Propalms, Inc.

Propalms, Inc. to Exhibit Propalms TSE to Over 2,000 Attendees At 2008 Microsoft Launch Wave Event in Atlanta

LAST $0.03 USD

Monday April 28, 8:31 am ET

MALTON, England, April 28, 2008 - Propalms, Inc. is pleased to announce that the Company will be exhibiting its TSE product at the 2008 Microsoft Launch Wave Event at the Georgia International Convention Center in Atlanta on April 29, 2008. This launch is a series of events that the Company was invited to join to celebrate Microsoft's new Windows Server 2008, Visual Studio 2008 and SQL Server 2008.

Microsoft estimates that the Atlanta event will reach over 2,000 attendees and the audience will primarily be made up of Technical Decision Makers, Business Decision Makers, IT Professionals, Developers and Database Administrators, amongst others. Propalms will be exhibiting its TSE software in the Microsoft Partner Pavilion. Propalms previously participated at the Microsoft Launch Wave Events in Los Angeles and Dallas, which resulted in positive results for the Company.

``As we attend additional Microsoft Launch Wave Events, we are able to make valuable connections within the industry that will benefit the Company significantly. It is an honor to be a part of the largest outreach to IT Professionals and Developers in Microsoft history and we look forward to exhibiting at future events,'' stated Owen Dukes, CEO of Propalms, Inc.

To find out more about the 2008 Microsoft Launch Wave Event in Atlanta, please visit: http://www.microsoft.com/heroeshappenhere/events/Atlanta/default.mspx.

Propalms will be hosting a Nationwide Teleconference on May 1, 2008 at 4:15 p.m. EST to update shareholders and the financial community on recent developments. There is expected to be a high demand for the call-in lines for this Nationwide Teleconference and space will be limited. Please call 1-866-THE-APPL recently to reserve your place and receive the information that will enable you to participate in the conference.

About Propalms, Inc.:

Propalms TSE, the complete Server-Based Management solution that extends Microsoft Terminal Services 2000/2003, offers features such as Application Publishing, Seamless Windows, Resource-based Load balancing, and Web-based management consoles.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

Sponsored by: http://www.isthemarketopen.com

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com

(OTCBB:INHIU), (OTCBB:SWCC), (OTCBB:VOIS), (OTCBB:TCHH).

Turning Pennies into dollars: (OTCBB:INHIU), (OTCBB:SWCC), (OTCBB:VOIS), (OTCBB:TCHH).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://inhiu.realpennies.com

(OTCBB:INHIU) InfuSystems Holdings, Inc..

InfuSystem Holdings Appoints Two New Board Members

LAST $3.25 USDr InfuSystem

Monday April 28, 7:30 am ET

InfuSystem Holdings, Inc. , the leading provider of ambulatory infusion pumps and associated clinical services, recently announced the appointment of David C. Dreyer and James L. Freddo, M.D. to the board of directors, bringing the total to eight members.

Mr. Dreyer has served as chief financial officer, chief accounting officer and treasurer of AMN Healthcare Services, Inc. since September 2004. Prior to that, he served as chief financial officer and chief accounting officer of Sicor, Inc., a manufacturer of complex pharmaceuticals with operations in the United States, Italy, Mexico, Lithuania, China and Switzerland, which was acquired by Teva Pharmaceutical Limited. Prior to joining Sicor in 1997, Mr. Dreyer served in related senior financial positions within the pharmaceutical industry for companies such as Elan Corporation plc, Athena Neurosciences and Syntex. Mr. Dreyer holds a Bachelors Degree from Golden Gate University in San Francisco and is a certified public accountant in California.

Dr. Freddo has served as chief medical officer of Anadys Pharmaceuticals, Inc. since July 2006. Prior to joining Anadys Pharmaceuticals, Dr. Freddo served as vice president, clinical site head and development site head at Pfizer Global Research and Development, La Jolla. From June 2002 until August 2005, Dr. Freddo served as executive director and site therapeutic area leader for oncology clinical development in La Jolla. While at Pfizer, Dr. Freddo led the team responsible for the registration of Sutent® , a drug approved by the U.S. Food and Drug Administration in January 2006 for the treatment of advanced kidney cancer and gastrointestinal stromal tumors. Prior to joining Pfizer, Dr. Freddo held a variety of senior management positions at Wyeth-Ayerst Research from December 1996 until June 2002, including senior director, oncology, senior director, infectious diseases, and senior director, transplantation immunology. Dr. Freddo holds a B.S. degree in Medical Technology from the State University of New York at Stony Brook and an M.D. degree from the University of North Carolina, where he also completed his fellowship training.

Mr. Sean McDevitt, chairman of the board, commented, "We are pleased to welcome David and James as the newest members of our board of directors, both of whom share our vision and commitment to improving the lives of cancer patients and helping to build InfuSystem into a world-class provider of ambulatory infusion pumps and associated clinical services for oncology practices and their patients. David has the ideal combination of both financial and healthcare experience, which will make him a valuable addition to our audit committee. James brings extensive medical and clinical experience, which will be an important resource as we accelerate our outreach activities within the healthcare community."

About InfuSystem Holdings, Inc.

InfuSystem is the leading provider of ambulatory infusion pumps and associated clinical services for oncology practices and their patients in the U.S. These pumps allow for the gradual delivery of a drug over a period of days in the privacy of one's home, compared to bolus infusion chemotherapy treatments that are given in a single high dose over a short period of time. Improved efficacy of the drugs, patient comfort, reimbursement to doctors for appropriate services and continuity of care all play a role in the growing trend toward this form of treatment. InfuSystem's pumps are primarily used for colorectal cancer, but they have been approved for other forms of cancer, thereby greatly enhancing the market opportunity for InfuSystem.

For more info: http://swcc.realpennies.com

(OTCBB:SWCC) Southwest Casino Corp.

Southwest Casino Corporation Announces Enactment of Law Permitting All-Breed Simulcasting at Running Aces Harness Park

LAST $0.68 USD

Monday April 28, 7:26 am ET

Southwest Casino Corporation announced recently that on Friday, April 25, 2008, Minnesota Governor Tim Pawlenty signed a bill into law under which the Minnesota Racing Commission is permitted to authorize Running Aces Harness Park to offer pari-mutuel wagering on simulcast races of all breeds of horses. Under the new law, Running Aces will be permitted to offer betting on televised races of thoroughbred and other horse breeds in addition to the harness race simulcasting already available at the racetrack. Running Aces must receive several approvals of its intended simulcasting schedule for thoroughbreds and other breeds, including the approval of the Minnesota Racing Commission before it can begin offering wagering on these additional races. Southwest Casino owns a 50 percent membership interest in Running Aces Harness Park.

Running Aces Harness Park offers live harness racing with pari-mutuel betting on a 5/8-mile racetrack in Columbus, Minnesota on the north side of the Twin Cities metropolitan area. During 2008, Running Aces will hold live racing from April 11 to July 6 on Friday, Saturday and Monday nights starting at 6:00 p.m. and Sunday afternoons starting at 3:00 p.m., as well as two Tuesday nights in June. In addition to live racing, Running Aces offers simulcast wagering on races from other tracks and a full service restaurant and bar open from 11 a.m. to 11 p.m. daily. Running Aces will also operate a card room with 50 gaming tables offering non-banked casino card games and live poker once it completes 50 days of live harness racing.

?We are pleased that this law will permit Running Aces to offer its customers access to races run at the best known horse tracks throughout the country in addition to the thrills of our live racing schedule,? said Jim Druck, Southwest?s CEO. ?We look forward to adding these additional races to the Running Aces entertainment package as soon as we can complete the approval process.?

About Southwest Casino Corporation

Southwest Casino Corporation develops, owns, operates, manages and provides consulting services to casinos, gaming facilities and related amenities. Southwest owns and operates the Gold Rush Hotel and Casino and Gold Digger?s Casino in Cripple Creek, Colorado. In addition, Southwest owns a 50 percent membership interest in North Metro Harness Initiative, LLC, which owns and operates Running Aces Harness Park. Southwest?s corporate offices are located at 2001 Killebrew Drive, Suite 350, Minneapolis, Minnesota 55425.

For more info: http://vois.realpennies.com

(OTCBB:VOIS) VOIS, Inc.

MDG Advertising Named as Agency of Record for Fast-Growing Social Network Vois.com

LAST $3.00 USD

Tuesday April 29, 5:36 am ET

BOCA RATON, FL-Apr 29, 2008 - Vois Inc. (pronounced "Voice") , one of the faster growing, global social commerce, social networking communities for people ages 25 to 50, announced recently that it has engaged MDG Advertising as its agency of record. MDG will provide Vois with comprehensive advertising and marketing services that will include ongoing strategic branding and integrated marketing.

As a full-service, award-winning advertising and design firm, MDG Advertising is renowned for developing exceptional creative strategies and strong brand identities that provide clients with competitive advantages in their specialized markets.

"MDG has an impressive record of developing innovative marketing and creative communications that are on target and on trend," said Gary Schultheis, President of Vois. "Their experience and knowledge will create a great partnership in helping reach its full potential."

About Vois Inc.

Vois.com is one of the faster growing, publicly traded global social commerce, social networking communities for people ages 25 to 50. Vois was recently awarded Favorite Photo Sharing Website and was a finalist for Favorite Large Scale Social Network at the 2007 Open Web Awards. - http://www.vois.com

About MDG Advertising

MDG Advertising is a full-service, award-winning advertising and design firm located in Boca Raton, FL. The agency has extensive experience developing strategic advertising solutions through integrated marketing, advertising, design, branding, direct marketing and interactive services.

For more info: http://tchh.realpennies.com

(OTCBB:TCHH) Trustcash Holdings, Inc.

Paivis, Corp. Announces It Expects to Complete Certain Key Merger Agreement Deliverables by May 15, 2008

LAST $0.03 USD

Monday April 28, 1:50 pm ET

ATLANTA, GA-Apr 28, 2008 - PAIVIS, CORP. recently announced it has progressed significantly on certain key deliverables required pursuant to the merger agreement with TRUSTCASH HOLDINGS, INC. . Specifically our internal technology audit is expected to be complete by May 15, 2008.

Edwin Kwong, the Interim Chief Executive Officer of PAIVIS, commented: "Upon Trustcash's filing of their 10K we commenced our final review and also expect to complete that important task between May 9 and May 15, 2008. We are going to keep up the pace to complete what has to be done under the merger agreement as quick as possible. We will continue to keep our shareholders informed."

About Paivis, Corp.

Paivis, Corp. is a wholesale telecommunications carrier that sells prepaid "point-of-sale activated" and live cards. Paivis generates its revenues through the sale of prepaid calling cards and wireless services, and international wholesale termination. Products are sold throughout many of the country's major retail outlets, including Duane Reade, 7-Eleven, and Chevron.

About Trustcash

Through its Trustcash brand and website www.trustcash.com, the Company is a pioneer of anonymous payment systems for the internet. It developed a business based on the sale of a stored value card that can be used by consumers to make secure and anonymous purchases on the internet without disclosing their credit card or personal information. Trustcash provides to its customers the "Trustcash" payment card, which is sold in denominations ranging from $10 to $200 online through any of over 500 websites. Trustcash's non-reloadable, virtual Trustcash card is the only "stored value card" that can be purchased where no personal data is stored or available, providing a unique level of both security and privacy to the purchaser.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

Sponsored by: http://www.isthemarketopen.com

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com

Turning Pennies into dollars: (NYSE:PCH), (NYSE: NUE), (NYSE: BSX), (NYSE: TRP)

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://pch.realpennies.com

Apr 17, 2008 - Potlatch Corporation (NYSE:PCH) announced today that its Board of Directors has authorized management to evaluate a potential tax-free spin-off of the Company's pulp-based businesses. A spin-off, if pursued, would create two stand-alone, publicly traded entities: a timber REIT, which is a verified forest practices leader with 1.65 million acres of forestland in Arkansas, Idaho, Minnesota and Wisconsin; and a pulp-based manufacturing company that would include Potlatch's Consumer Products facilities in Lewiston, Idaho, Las Vegas, Nevada, and Elwood, Illinois, and its Pulp & Paperboard facilities in Lewiston, Idaho, and Cypress Bend, Arkansas. The businesses to be evaluated for spin-off had revenues of approximately $1.2 billion in 2007.

For more info: http://nue.realpennies.com

Apr 17, 2008 - Nucor Corporation (NYSE: NUE) announced today record first quarter net earnings for the fifth consecutive year. Consolidated net earnings for the first quarter of 2008 were $409.8 million, an increase of 8% compared to the first quarter of 2007 net earnings of $381.0 million and an increase of 12% from the fourth quarter of 2007 net earnings of $364.8 million. Diluted earnings per share increased 12% to $1.41 from $1.26 in the first quarter of 2007 and in the fourth quarter of 2007. The increase in earnings per share from the first quarter of 2007 is partially due to the reduced number of shares outstanding as a result of stock repurchases made in 2007. Nucor's consolidated net sales increased 32% to a record $4.97 billion compared with $3.77 billion in the first quarter of 2007 due to a 15% increase in average steel sales price per ton, an 11% increase in average steel products sales price per ton, and a significant increase in steel products shipments attributable to acquisitions made in 2007. The increase in sales is also due to the February 29, 2008 acquisition of the stock of SHV North America Corporation, which owns 100% of The David J. Joseph Company ("DJJ") and its affiliates, for a cash purchase price of approximately $1.4 billion. DJJ, which now operates as a wholly owned subsidiary of Nucor Corporation, has been the broker of ferrous scrap to Nucor since 1969.

For more info: http://bsx.realpennies.com

April 17, 2008-- Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval for the sale of its TAXUS(R) Liberte(R) paclitaxel-eluting coronary stent system in Canada. The Company reported that Health Canada's Therapeutic Products Directorate (TPD), the authority that regulates pharmaceutical drugs and medical devices, has approved its use. The Company said it plans to launch the product immediately in Canada. "The TAXUS Liberte Stent is a major advance in stent development and raises the bar for drug-eluting stent systems," said Serge Doucet, M.D., Cathlab Director at the Montreal Heart Institute. "It offers enhanced ability to conform to the vessel wall and deliver across some of the most challenging lesions. This innovation is welcome news for interventional cardiologists and patients in Canada who suffer from coronary artery disease."

For more info: http://trp.realpennies.com

Apr 17, 2008 -- TransCanada Corporation (NYSE: TRP) (TransCanada) today announced Bruce Power has completed its comprehensive review of costs to complete the Bruce A Units 1 and 2 Restart Project. The review, which was completed by Bruce Power, its owners and independent experts with significant experience in energy infrastructure mega-projects, included a thorough assessment of costs incurred to date together with a complete review of the remaining work. Based on the assessment the capital cost for the restart and refurbishment of Bruce A Units 1 and 2 is expected to be in the range of $3.1 to $3.4 billion, up from an original 2005 cost estimate of $2.75 billion. TransCanada's share is $1.55 to $1.7 billion compared to an original estimate of $1.375 billion. The project cost increases are subject to the capital cost risk and reward sharing mechanism under the agreement with the OPA.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

Sponsored by: http://www.isthemarketopen.com

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com

(OTCBB: CPTC), (OTCBB: BVTI), (OTCBB: SLTN).

Turning Pennies into dollars: (OTCBB: CPTC), (OTCBB: BVTI), (OTCBB: SLTN).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://cptc.realpennies.com

Composite Technology Corporation (OTCBB: CPTC) up 5.6% on 2.7 million shares traded.

Composite Technology Corporation, based in Irvine, California, USA, develops, manufactures and sells innovative high performance electrical transmission and renewable energy generation products through its subsidiaries: CTC Cable Corporation & DeWind Inc. On April 16th, the company was pleased to announce the commissioning of ACCC* conductor on a critical main artery transmission line feeding power to the Polish capital city of Warsaw. The order for the delivery of 350 kilometers (218 miles) of ACCC 460 mm2 "Stockholm" conductor and hardware is the first commercial use of ACCC conductors in continental Europe. In a landmark installation, six local contractors worked simultaneously on different sections of a 96 kilometer (60 mile) transmission line over a 30 day period installing the ACCC conductor and hardware. Outage time was limited due to the critical nature of the line.

For more info: http://bvti.realpennies.com

Biovest International, Inc. (OTCBB: BVTI) up 20.1% on 1.3 million shares traded.

Biovest International, Inc. is a pioneer in the development of advanced individualized immunotherapies for life-threatening cancers of the blood system. On April 17th, the company announced that a key milestone has been achieved in the Company's mission to gain approval for BiovaxID(R), its personalized anti-cancer vaccine, in a pivotal Phase 3 Fast-Tracked clinical trial for the treatment of indolent follicular non-Hodgkin's lymphoma.

For more info: http://sltn.realpennies.com

Solar Thin Films, Inc. (OTCBB: SLTN) up 32.9% on 757,000 shares traded.

Solar Thin Films (www.solarthinfilms.com) develops, manufactures and markets a complete line of manufacturing equipment for the production of "thin-film" amorphous silicon and CIGS photovoltaic ("PV") modules, together with a wholly owned subsidiary based in Budapest, Hungary. On April 17th, the company announced that it has received an order from Grupo Unisolar, S.A. ("Grupo Unisolar") to build a 5MW turn-key a-SI Module thin film photovoltaic manufacturing plant. The facility, which will be based in Spain, will be sold to Grupo Unisolar for an aggregate purchase price of $12,300,000. In connection with the sale of the plant, the Company also agreed to provide certain installation and testing services to Grupo Unisolar. Solar Thin Films CEO, Peter Lewis, stated, "We are delighted to be associated with Grupo Unisolar. Our thin film technology presents a solution that is both cost effective and environmentally friendly."

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

Sponsored by: http://www.isthemarketopen.com

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com

Turning Pennies into dollars: (Pink Sheets: STHG), (OTCBB: CBMC), (OTCBB: BVTI), (OTCBB: WSEG).

Turning Pennies into dollars: (Pink Sheets: STHG), (OTCBB: CBMC), (OTCBB: BVTI), (OTCBB: WSEG).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://sthg.realpennies.com

Steadfast Holdings Group, Inc. (Pink Sheets: STHG) (April 17, 2008, 7:00am ET) Steadfast Holdings Group, Inc. announced that its Steadfast Automotive stores have begun selling a proprietary spray-on formulation of UV-protectant for all types of truck bed liners, that the Company is branding "Steadfast Rejuvenator." The protectant blocks ultra violet rays which cause bed liners to fade and crack.

John Calash, CEO of Steadfast Holdings Group, Inc., stated, "We know from our sales experience with our commercial and consumer customers that they need a superior spray UV-protectant product to extend the life of their truck's bed liners. Consequently, we had formulated exclusively for us a unique, high performance spray UV-protectant which we are marketing through our stores, and eventually through other accessory stores as well.

We believe Steadfast Rejuvenator is unsurpassed by any comparable product in the market in performance and value for the price. It is yet but one more example of how we are approaching our growth innovatively with high margin product, in order to build incremental revenue and profit."

About Steadfast Holdings Group, Inc.

Steadfast Holdings Group distributes a variety of products to the automotive aftermarket. The core business is its spray on truck bed protection product which offers specially formulated polymers that permanently bond to the truck's bed. The Company's spray-on Polyurea is a remarkable technology with a range of uses limited only by your imagination. They are also utilized in commercial, industrial, agricultural, military and custom applications when this tough coating is used to protect everything from metals to concrete against chemicals, solvents, fuel, etc. The Company is a licensed dealer for the following aftermarket products: A.R.E. Truck Caps and Lids, Tool Boxes, Nerf Bars, Tube Steps, Running Boards, Rack Systems, Rail Caps, Tonneau Covers, Fender Flares, Grilles, Visors, Bug Shields, Roll-Up Covers, Side Rails, Mud Guards, Floor Mats, Lights, Trailer Hitches, Stainless Steel Accessories and Lift Kits. Steadfast also has distribution agreements with the several companies that manufacture light truck aftermarket products. Additional information may be found at www.steadfastlinings.com.

For more info: http://cbmc.realpennies.com

Calypte Biomedical Corporation (OTCBB: CBMC) Calypte Biomedical Corporation, a developer, manufacturer and marketer of HIV diagnostic tests, announced that its Chinese subsidiary, Beijing Marr Bio-Pharmaceutical Co. Ltd. ("Beijing Marr"), has received registration and marketing approval for Calypte's Aware HIV-1/2 OMT (oral fluid) rapid test from the State Food and Drug Administration ("SFDA") of China. This approval makes the Aware HIV-1/2 OMT test the first and only SFDA approved rapid oral fluid HIV test in China.

Roger Gale, Calypte's Chairman and Chief Executive Officer, stated, "This is a major accomplishment for Calypte and we are thrilled to have received this long awaited approval which permits us to begin actively marketing our rapid diagnostic tests in China, one of the potentially largest HIV testing markets in the world. With the medical devices manufacturing permit received earlier this year, our Beijing Marr subsidiary is now able to manufacture, market, distribute and sell the Aware HIV-1/2 OMT test throughout the Peoples' Republic of China. China is committed to aggressively tackle the spread of its HIV epidemic and we believe that our Aware HIV-1/2 OMT (oral fluid) test can and will make a significant contribution to that effort. We appreciate the patience of those investors who have supported us through the long SFDA approval process, particularly our joint venture partners, the Marr Group." Mr. Gale added, "This approval also gives us, for the first time, a very valuable approval in the country of manufacture. Absence of this approval in the past has hampered our ability to register and market the test in a number of countries, a hurdle we can now overcome by producing the domestically approved Aware product in our Chinese factory. With this SFDA approval, we are now in a position to market and sell in countries representing a total population of nearly 3.7 billion, or over half of the worlds' population."

Dr. Ronald Mink, Chief Science Officer for Calypte, remarked, "This approval has validated our perseverance in pursuing the registration of a product in which we have long had confidence. The transformation of the SFDA over the past two to three years into a first tier agency matching the rigor and integrity of its U.S. and European counterparts resulted in a very thorough review of the Aware HIV-1/2 OMT (oral fluid) test. We believe that the Chinese authorities are now comfortable with this new technology, which expands the scope of testing platforms currently available in China.

The SFDA's restructuring has resulted in a review process and timetable that is similar to what we see in the U.S. FDA. We believe these changes will benefit not only China, by setting a higher standard for new medical products, but will also benefit us, by setting a higher barrier to market entry for would-be competitors. Throughout the entire review process, we received continually positive feedback from the SFDA and we have been confident that our technology is solid and our registration would prevail."

David Harris, Beijing Marr's Chief Executive Officer, stated, "This is a very exciting moment for those of us at Beijing Marr who have worked very hard to gain this approval and ready the factory for manufacture, sale and distribution of the Aware HIV-1/2 OMT test. We have already received numerous inquiries from HIV program managers and scientists eager to use the product here in China. We now plan to ramp up our production capacity as we build our distribution network to fully realize the market potential of the Aware HIV-1/2 OMT test in China. Beijing Marr is committed to, and enthusiastic about, bringing this exciting new technology to the Chinese medical community."

Calypte operates in China through Beijing Marr, a joint venture between Calypte and the Marr Group established to manufacture Calypte's Aware line of rapid HIV tests, including the Aware HIV-1/2 OMT product for both the Chinese and international markets. Beijing Marr operates an ISO 13485:2003 certified manufacturing facility on the outskirts of Beijing. The Aware HIV-1/2 OMT product is a rapid test using oral fluid to diagnose HIV-1 or HIV-2 infection in as little as 20 minutes with an accuracy comparable to that of U.S. FDA approved blood based laboratory HIV EIA tests.

For more info: http://bvti.realpennies.com

Biovest International, Inc. (OTCBB: BVTI) (Thu, April 17, 2008, 8:00am ET) Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), announced that a key milestone has been achieved in the Company's mission to gain approval for BiovaxID , its personalized anti-cancer vaccine, in a pivotal Phase 3 Fast-Tracked clinical trial for the treatment of indolent follicular non-Hodgkin's lymphoma.

Biovest reported that the independent Data Monitoring Committee (DMC), which is vested with the responsibility of monitoring the safety and efficacy of the BiovaxID trial, has completed a closed session review of the unblinded results, including the primary and secondary endpoints analysis of the Phase 3 study. Based on their analysis, the DMC has recommended that the results be unblinded, and has volunteered to participate, if needed, in Biovest's ongoing regulatory meetings with the U.S. Food and Drug Administration (FDA) and other worldwide regulatory agencies (Health Authorities) in order to determine the most appropriate process for unblinding the results, and establishing a pathway to seek marketing approvals.

The Chairman of the DMC, Dr. Gerald Messerschmidt, reported, "Our Committee has completed a closed session unblinded review of the interim Phase 3 safety and efficacy analyses regarding the BiovaxID registration study. Based on this review, the DMC recommends that the BiovaxID study be unblinded to the Company for final analysis. We further suggest that the final clinical study report include data, as part of Biovest's overall regulatory strategy of submission to the regulatory authorities, through August 29, 2008, which is the date when the last randomized and vaccinated patient reaches 12-months follow-up from first injection. While the DMC cannot release information on our closed session discussions, our recommendation to unblind this pivotal registration study in late-August is based on the status of the study, the defined safety profile over 8-years of this Phase 3 registration study and our review of the primary and secondary endpoint analyses. As part of the ongoing regulatory process, I as a representative of the DMC will relate our review of the closed session analysis of these interim data to Health Authorities as necessary."

Responding to the DMC's recommendations, Biovest's Chairman and CEO, Dr. Steven Arikian, stated, "The DMC's diligent review has resulted in an excellent outcome for BiovaxID. Not only has the Committee reconfirmed the favorable safety profile for BiovaxID, but as importantly, we believe their recommendation to unblind and their willingness to meet with the regulatory authorities to discuss their findings suggests a successful trial outcome. In light of the DMC's recommendation, we have already been in discussions with regulatory agencies, including the FDA, to seek consensus on the appropriate process for unblinding the results and establishing a pathway for potential accelerated and/or conditional approvals for BiovaxID. We also are coordinating with the EMEA regarding potential market access in Europe. If approved, Biovest will have distinguished itself as the first company to have its anti-cancer vaccine reach market in the U.S. or EU, a Herculean achievement. As this study was initiated in 2000, we now have the largest longitudinal database of lymphoma patients receiving a personalized therapeutic vaccine. 234 patients were enrolled and 177 randomized in the Phase 3 trial of which, two-thirds received BiovaxID therapy, and one-third control treatment. We believe that these long-term and highly anticipated results will demonstrate that BiovaxID is capable of prolonging the period of disease-free survival for an incurable form of non-Hodgkin's lymphoma, and in some cases, perhaps even inducing indefinitely prolonged, durable remissions."

As previously presented to the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO), the National Cancer Institute (NCI) demonstrated in a Phase 2 clinical trial that patients treated with BiovaxID achieved: a median disease-free survival of over eight years; a 95% overall survival rate after 9.2 years of follow-up; and a 95% cellular immune response. In this clinical trial, 73% of evaluable patients were converted into molecular remission (bcl-2 negative), evidence that their blood has been cleared of residual cancerous cells. BiovaxID also demonstrated an outstanding safety profile.

According to Dr. Angelos M. Stergiou, Biovest's Vice President, Product Development, Medical Affairs & Clinical Research, "This Phase 2 data, combined with our analysis of the blinded Phase 3 results, and the DMC's recommendation to unblind, gives us a high level of confidence in unblinding the current Phase 3 study, both for efficacy and safety. If the results are highly positive, and assuming we are granted accelerated approval for BiovaxID, we would anticipate initiating a Phase 4, post-approval, clinical study for the purpose of collecting further efficacy and safety data."

The primary end-point of the trial is a comparison between treatment groups, those that receive BiovaxID and those that receive a control. The study is looking at duration of disease-free survival measured from the time of randomization (i.e. when a subject is randomly assigned to receive BiovaxID or control) to the time of confirmed relapse.

For more info: http://wseg.realpennies.com

Western Standard Energy Corp. (OTCBB: WSEG) (Thu, April 17, 2008, 9:3 0am ET) Western Standard Energy Corp., (hereafter "Western Standard" or "the Company"), an oil and gas exploration company, is pleased to announce its second drilling permit from the Bureau of Land Management, a department of the U.S. Department of the Interior. The permit was granted to its operator partner, Coastal Petroleum, for a second well on the Starbuck East prospect in Valley County, Montana. The permit pertains to a well location at Federal 1-21, which is a step-out well from the exploration well at Federal 1-19 drilled to approximately 1,000 feet in October, 2007, and currently remains on hold for completion and testing due to Federal land restrictions on access and usage until July 1 based on environmental and wildlife obligations.

The timing of the permit came prior to the recent results of a US Geological Survey ("USGS") report that assessed the Undiscovered Oil Resources in the Williston Basin where Western Standard has a 50% interest in the Starbuck East Prospect, as well a 25% interest in a State Lease, both areas combined to approximately 100,000 acres in Valley County, Montana. This is in addition to the company's 8 Lodgepole Reef prospects within the Williston Basin, in North Dakota.

According to the report released on April 10 by the USGS, "North Dakota and Montana have an estimated 3.0 to 4.3 billion barrels of undiscovered, technically recoverable oil in an area known as the Bakken Formation." This estimate shows a significant leap from an estimate made by the government agency during its last assessment of the area in 1995, which showed a potential recoverable 151 million barrels of oil.

"Upon successful completion of our exploration well at the Federal 1-19, we plan to drill a second well on the Starbuck East lease at Federal 1-21," stated Dan Bauer, President and CEO of Western Standard Energy. "With the recent assessment by the USGS on the potential for this area, we have plans for further land acquisitions and will continue to assess opportunities to exploit the production potential of our current prospects."

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

Sponsored by: http://www.isthemarketopen.com

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com